Description

LISTRIL 10 MG (1X15)

Indications

LISTRIL 10 MG is primarily indicated for the management of hypertension, which is a condition characterized by elevated blood pressure. It is also effective in the treatment of heart failure and is often prescribed after myocardial infarction to improve survival rates. In some cases, LISTRIL may be utilized for the prevention of kidney complications in patients with diabetes mellitus.

Mechanism of Action

LISTRIL contains the active ingredient lisinopril, which is an angiotensin-converting enzyme (ACE) inhibitor. By inhibiting the ACE enzyme, lisinopril prevents the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor. This action leads to vasodilation, reduced blood pressure, and decreased workload on the heart. Additionally, ACE inhibition promotes increased levels of bradykinin, which further contributes to vasodilation and offers potential cardioprotective effects.

Pharmacological Properties

Lisinopril is well absorbed after oral administration, with peak plasma concentrations occurring approximately 7 hours post-dose. The bioavailability of lisinopril is approximately 25% to 30%. It exhibits a long half-life, allowing for once-daily dosing. Lisinopril is primarily excreted unchanged in the urine, making it suitable for patients with renal impairment, although dose adjustments may be necessary. The pharmacokinetics of lisinopril are not significantly affected by food intake.

Contraindications

LISTRIL 10 MG is contraindicated in patients with a known hypersensitivity to lisinopril or any other ACE inhibitors. It should not be used in individuals with a history of angioedema related to previous ACE inhibitor therapy. Additionally, the medication is contraindicated during pregnancy, particularly in the second and third trimesters, due to the risk of fetal harm. Patients with severe renal impairment or those undergoing dialysis should also avoid this medication unless closely monitored by a healthcare professional.

Side Effects

Common side effects associated with LISTRIL 10 MG include dizziness, headache, fatigue, and dry cough. Some patients may experience gastrointestinal disturbances such as nausea or diarrhea. Serious side effects, though less common, can include hypotension, hyperkalemia, renal impairment, and angioedema. It is important for patients to report any unusual symptoms to their healthcare provider, especially signs of swelling or difficulty breathing, which may indicate an allergic reaction.

Dosage and Administration

The recommended starting dose of LISTRIL for the treatment of hypertension in adults is typically 10 mg once daily. Depending on the patient’s response, the dosage may be adjusted, with a maximum recommended dose of 40 mg per day. For heart failure management, the initial dose may be lower, typically starting at 2.5 mg to 5 mg once daily, with gradual titration based on tolerance and clinical response. In patients with renal impairment, dose adjustments are necessary, and careful monitoring of renal function is advised.

Interactions

LISTRIL may interact with various medications, which can alter its effectiveness or increase the risk of adverse effects. Notably, the concurrent use of potassium-sparing diuretics or potassium supplements may lead to hyperkalemia. Nonsteroidal anti-inflammatory drugs (NSAIDs) can reduce the antihypertensive effect of lisinopril and may impair renal function. Caution should also be exercised when combining lisinopril with other antihypertensive agents, as this may lead to additive hypotensive effects. Patients should inform their healthcare provider of all medications they are taking, including over-the-counter drugs and supplements.

Precautions

Before starting therapy with LISTRIL 10 MG, a thorough medical history should be obtained, and baseline renal function should be assessed. Patients with a history of renal artery stenosis or those who are volume-depleted should be monitored closely, as they may be at increased risk for hypotension and renal impairment. Regular monitoring of blood pressure, renal function, and electrolytes is recommended during treatment. Additionally, patients should be advised to avoid sudden discontinuation of the medication, as this may lead to rebound hypertension.

Clinical Studies

Clinical studies have demonstrated the efficacy of lisinopril in reducing blood pressure and improving clinical outcomes in patients with heart failure and those post-myocardial infarction. In a randomized controlled trial, lisinopril was shown to significantly lower systolic and diastolic blood pressure compared to placebo. Furthermore, studies have indicated that long-term use of lisinopril is associated with a reduction in cardiovascular morbidity and mortality in high-risk populations. The drug’s favorable safety profile and tolerability make it a first-line treatment option for hypertension and heart failure.

Conclusion

LISTRIL 10 MG is a well-established medication for the management of hypertension, heart failure, and post-myocardial infarction care. Its mechanism of action as an ACE inhibitor provides significant benefits in lowering blood pressure and improving cardiovascular outcomes. While generally well-tolerated, it is essential for patients to be aware of potential side effects and drug interactions. Regular monitoring and appropriate dosing adjustments are crucial to ensure safe and effective treatment. As always, patients should consult their healthcare provider for personalized medical advice and management.